Huanyu Chen

2.7k citations
63 papers · 1.8k indexed · 1 hit paper · h-index 18

Huanyu Chen

54 papers receiving 1.7k citations

Hit Papers

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatm...185202320262024202550100150

Peers

Huanyu Chen
Comparison fields: 5 of 150
  • Oncology 831
  • Nephrology 169
  • Pulmonary and Respiratory Medicine 587
  • Cancer Research 268
  • Critical Care and Intensive Care Medicine 51
Replace Jun Shao with:
Jun Shao China
Hans‐Helge Müller Germany
Wen‐Ping Wang China
Chang Wook Jeong South Korea
Abhishek Mahajan India
Nan Chen China
Sven H. Loosen Germany
Éric Vibert France
Masahiro Kuroda Japan
Jin Yang China
Huanyu Chen relative to Jun Shao China Jun Shao's profile →
Citations per field
00.5×11.9×
Jun Shao · 1×
Citations per year

Countries citing papers authored by Huanyu Chen

Since Specialization
Citations

This map shows the geographic impact of Huanyu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanyu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanyu Chen more than expected).

Fields of papers citing papers by Huanyu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanyu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanyu Chen. The network helps show where Huanyu Chen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Huanyu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Huanyu Chen Line = papers co-authored together Huanyu Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20250
5 20250
6 20241
7 20231
8 202326
9 20231
10 20233
11 20221
12 20225
13 202115
14 202110
15 202115
16 20217
17 2018112
18 2018171
19 201742
20 201221

About Huanyu Chen

Huanyu Chen is a scholar working on Leadership and Management, Oncology and Computer Vision and Pattern Recognition, having authored 63 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (6 papers), Gastric Cancer Management and Outcomes (6 papers), Esophageal Cancer Research and Treatment (5 papers), Face recognition and analysis (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Oncology (831 citations), Nephrology (169 citations) and Pulmonary and Respiratory Medicine (587 citations). Huanyu Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Richard Pazdur, Patricia Keegan, Kun He, Gideon M. Blumenthal, Roslyn A. Stone, Robert Justice, Kirsten B. Goldberg, Hong Zhao, Dickran Kazandjian and Mona Patel. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026